Natalya EG. Immune Biomarkers of Percutaneous Coronary Intervention Adverse Outcomes in Myocardial Infarction and Stable Angina Patients. AJP [Internet]. 2018 Nov. 6 [cited 2024 May 2];12(03). Available from: http://asiapharmaceutics.info/index.php/ajp/article/view/2653